Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial
Sara Fernández-Castillejo,Joan Badia,Luís de la Cruz-Merino,Alejandro Martín Garcia-Sáncho,Fernando Carnicero-González,Natalia Palazón-Carrión,Eduardo Ríos-Herranz,Fátima de la Cruz-Vicente,Antonio Rueda-Domínguez,Natividad Martínez-Banaclocha,José Gómez-Codina,Jorge Labrador,Francisca Martínez-Madueño, Núria Amigó,Antonio Salar-Silvestre, Delvys Rodríguez-Abreu, Laura Gálvez-Carvajal,Margarita Sánchez-Beato,Mariano Provencio-Pulla, Maria Guirado-Risueño, Esteban Nogales, Víctor Sánchez-Margalet,Carlos Jiménez-Cortegana, Guillermo Rodríguez-García,Raquel Cumeras,Josep Gumà, Spanish Lymphoma Oncology Group (GOTEL) Cancers（2025）
Key words
ketone bodies,diffuse large B-cell lymphoma (DLBCL),relapsed/refractory lymphoma,3-hydroxybutyrate,3OHB,acetone,prognostic biomarkers,metabolomics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper